GSK3B and lung carcinoma: In a xenograft mouse model of multicellular tumor spheroids containing lung cancer cells and human umbilical vein endothelial cells (HUVECs), GSK-3β inhibition reduced the lung cancer volume by inhibiting EndMT, and had a synergistic anticancer effect on non-small-cell lung cancer cells in combination with gefitinib63.